Evidence map›Paper›PMID 26186022›Full record

ArticleHuman vaccines & immunotherapeutics2016

CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy.

Lena M Kranz, Matthias Birtel, Christina Krienke, Christian Grunwitz, Jutta Petschenka, Kerstin C Reuter, Niels van de Roemer, Fulvia Vascotto, Mathias Vormehr, Sebastian Kreiter and 1 more

Abstract readConference Proceedings
In one paragraph

Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lena M Kranza TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Matthias Birtela TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Christina Krienkea TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Christian Grunwitza TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Jutta Petschenkaa TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Kerstin C Reuterc BioNTech RNA Pharmaceuticals GmbH ; Mainz , Germany.
Niels van de Roemera TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Fulvia Vascottoa TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Mathias Vormehra TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Sebastian Kreitera TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.
Mustafa Dikena TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH ; Mainz , Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer VaccinesCell TransplantationCombined Modality TherapyHumansImmunotherapyNeoplasmsPrecision MedicineCancer Vaccinescancer immunotherapycellular therapyCIMTcombination therapypersonalized therapytumor microenvironmenttumor vaccination

Identifiers

PMID26186022
PMCPMC4962731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.